https://www.selleckchem.com/pr....oducts/pf-2545920.ht
A case of clinical management of a patient with neurological complications of COVID-19 is described. In the long term, COVID-19 stimulates neurodegenerative changes, which require specific programs of neurological rehabilitation. It is advisable to use choline drugs and antihypoxants that are compatible with COVID-19 therapy. In the long term, COVID-19 stimulates neurodegenerative changes, which require specific programs of neurological rehabilitation. It is advisable to use choline drugs and antihypoxants that are compatible with CO
Like
Comment
Share